论文部分内容阅读
来自于意大利米兰大学的Nicola Principi博士及其同事在近期的《医学病毒学杂志》(JMV)上刊文报道说,衣壳病毒颗粒流感疫苗对接受高效抗逆转录病毒治疗(HAART)的H1V感染患儿是“安全而适度的免疫原性”。Principi博士及其同事对肌肉注射病毒颗粒流感疫苗影响29例接受HAART的HIV感染患儿的免疫原性以及疫苗印象病毒复制和T细胞活化的作用进行了评估;其中10例患儿未曾接种过抗流感疫苗,
Nicola Principi and colleagues from the University of Milan, Italy, reported in a recent article in the Journal of Medical Virology (JMV) that the capsid virion influenza vaccine was effective against H1V infection with highly active antiretroviral therapy (HAART) Children are “safe and modest immunogenicity.” Principi and colleagues evaluated the immunogenicity of 29 HIV-infected HIV-infected children as well as the impact of vaccine-impression virus replication and T-cell activation on the intramuscular injection of a virosavirus vaccine; 10 of these children had never been vaccinated Flu vaccine,